FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281567298> ?p ?o ?g. }

• W4281567298 endingPage "692" @default.
• W4281567298 startingPage "669" @default.
• W4281567298 abstract "Background & AimsParenteral nutrition (PN) is a lifesaving therapy for patients with intestinal failure. Hepatic steatosis is a potentially fatal complication of long-term PN, but the involved pathological mechanisms are incompletely unclarified. Herein, we identify the role of protein phosphatase 2A (PP2A) in the pathogenesis of parenteral nutrition-associated hepatic steatosis (PNAHS).MethodsProteomic/phosphoproteomic analyses of liver samples from patients with PNAHS were applied to identify the mechanism of PNAHS. Total parenteral nutrition (TPN) mice model, in vivo, and in vitro experiments were used to assess the effect of PP2A-Cα on liver fatty acid metabolism.ResultsReduced expression of PP2A-Cα (catalytic subunit) enhanced activation of serine/threonine kinase Akt2 and decreased activation of adenosine monophosphate-activated protein kinase (AMPK) were associated with hepatic steatosis in patients with PNAHS. Mice given PN for 14 days developed hepatic steatosis, down-regulation of PP2A-Cα, activation of Akt2, and inhibition of AMPK. Hepatocyte-specific deletion of PP2A-Cα in mice given PN exacerbated Akt2 activation, AMPK inhibition, and hepatic steatosis through an effect on fatty acid degradation, whereas hepatocyte-specific PP2A-Cα overexpression significantly ameliorated hepatic steatosis accompanied with Akt2 suppression and AMPK activation. Additionally, pharmacological activation of Akt2 in mice overexpressing PP2A-Cα led to the aggravation of hepatic steatosis.ConclusionsOur findings demonstrate that hepatic PP2A-Cα serves as a protective factor of PNAHS due to ameliorating hepatic steatosis and improving liver function. Our study provides a strong rationale that PP2A-Cα may be involved in the pathogenesis of PNAHS. Parenteral nutrition (PN) is a lifesaving therapy for patients with intestinal failure. Hepatic steatosis is a potentially fatal complication of long-term PN, but the involved pathological mechanisms are incompletely unclarified. Herein, we identify the role of protein phosphatase 2A (PP2A) in the pathogenesis of parenteral nutrition-associated hepatic steatosis (PNAHS). Proteomic/phosphoproteomic analyses of liver samples from patients with PNAHS were applied to identify the mechanism of PNAHS. Total parenteral nutrition (TPN) mice model, in vivo, and in vitro experiments were used to assess the effect of PP2A-Cα on liver fatty acid metabolism. Reduced expression of PP2A-Cα (catalytic subunit) enhanced activation of serine/threonine kinase Akt2 and decreased activation of adenosine monophosphate-activated protein kinase (AMPK) were associated with hepatic steatosis in patients with PNAHS. Mice given PN for 14 days developed hepatic steatosis, down-regulation of PP2A-Cα, activation of Akt2, and inhibition of AMPK. Hepatocyte-specific deletion of PP2A-Cα in mice given PN exacerbated Akt2 activation, AMPK inhibition, and hepatic steatosis through an effect on fatty acid degradation, whereas hepatocyte-specific PP2A-Cα overexpression significantly ameliorated hepatic steatosis accompanied with Akt2 suppression and AMPK activation. Additionally, pharmacological activation of Akt2 in mice overexpressing PP2A-Cα led to the aggravation of hepatic steatosis. Our findings demonstrate that hepatic PP2A-Cα serves as a protective factor of PNAHS due to ameliorating hepatic steatosis and improving liver function. Our study provides a strong rationale that PP2A-Cα may be involved in the pathogenesis of PNAHS." @default.
• W4281567298 created "2022-05-27" @default.
• W4281567298 creator A5008694922 @default.
• W4281567298 creator A5010478248 @default.
• W4281567298 creator A5011668923 @default.
• W4281567298 creator A5011869206 @default.
• W4281567298 creator A5021388534 @default.
• W4281567298 creator A5030528829 @default.
• W4281567298 creator A5049078993 @default.
• W4281567298 creator A5066716873 @default.
• W4281567298 creator A5069139562 @default.
• W4281567298 creator A5071521060 @default.
• W4281567298 creator A5071887725 @default.
• W4281567298 creator A5086242915 @default.
• W4281567298 creator A5089508417 @default.
• W4281567298 creator A5089774868 @default.
• W4281567298 date "2022-01-01" @default.
• W4281567298 modified "2023-09-26" @default.
• W4281567298 title "Liver PP2A-Cα Protects From Parenteral Nutrition-associated Hepatic Steatosis" @default.
• W4281567298 cites W1772774963 @default.
• W4281567298 cites W1919998081 @default.
• W4281567298 cites W1963917835 @default.
• W4281567298 cites W1964823824 @default.
• W4281567298 cites W1967066877 @default.
• W4281567298 cites W1968091833 @default.
• W4281567298 cites W1970205234 @default.
• W4281567298 cites W1982099507 @default.
• W4281567298 cites W1991864822 @default.
• W4281567298 cites W1995030297 @default.
• W4281567298 cites W1999793253 @default.
• W4281567298 cites W2006686491 @default.
• W4281567298 cites W2018511096 @default.
• W4281567298 cites W2022075010 @default.
• W4281567298 cites W2031236987 @default.
• W4281567298 cites W2035970641 @default.
• W4281567298 cites W2053073281 @default.
• W4281567298 cites W2063897784 @default.
• W4281567298 cites W2066382000 @default.
• W4281567298 cites W2066893159 @default.
• W4281567298 cites W2067740038 @default.
• W4281567298 cites W2070119291 @default.
• W4281567298 cites W2090429237 @default.
• W4281567298 cites W2095063281 @default.
• W4281567298 cites W2099579483 @default.
• W4281567298 cites W2117630883 @default.
• W4281567298 cites W2122565002 @default.
• W4281567298 cites W2123344659 @default.
• W4281567298 cites W2126479503 @default.
• W4281567298 cites W2131799284 @default.
• W4281567298 cites W2134357919 @default.
• W4281567298 cites W2146854995 @default.
• W4281567298 cites W2159750196 @default.
• W4281567298 cites W2165421630 @default.
• W4281567298 cites W2165911612 @default.
• W4281567298 cites W2168330194 @default.
• W4281567298 cites W2170704593 @default.
• W4281567298 cites W2170781174 @default.
• W4281567298 cites W221618059 @default.
• W4281567298 cites W2252662712 @default.
• W4281567298 cites W2290952291 @default.
• W4281567298 cites W2410140515 @default.
• W4281567298 cites W2423008247 @default.
• W4281567298 cites W2436734185 @default.
• W4281567298 cites W2462514513 @default.
• W4281567298 cites W2515115215 @default.
• W4281567298 cites W2581434358 @default.
• W4281567298 cites W2591569186 @default.
• W4281567298 cites W2598068944 @default.
• W4281567298 cites W2740414785 @default.
• W4281567298 cites W2786307681 @default.
• W4281567298 cites W2796741314 @default.
• W4281567298 cites W2797052498 @default.
• W4281567298 cites W2799813397 @default.
• W4281567298 cites W2804989915 @default.
• W4281567298 cites W2904802960 @default.
• W4281567298 cites W2906748726 @default.
• W4281567298 cites W2918152805 @default.
• W4281567298 cites W2944694507 @default.
• W4281567298 cites W2950874120 @default.
• W4281567298 cites W2967458104 @default.
• W4281567298 cites W2971508249 @default.
• W4281567298 cites W2991726314 @default.
• W4281567298 cites W3035174495 @default.
• W4281567298 cites W3040947887 @default.
• W4281567298 cites W3091754470 @default.
• W4281567298 cites W3189752678 @default.
• W4281567298 cites W4240253200 @default.
• W4281567298 doi "https://doi.org/10.1016/j.jcmgh.2022.05.008" @default.
• W4281567298 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35643235" @default.
• W4281567298 hasPublicationYear "2022" @default.
• W4281567298 type Work @default.
• W4281567298 citedByCount "2" @default.
• W4281567298 countsByYear W42815672982022 @default.
• W4281567298 crossrefType "journal-article" @default.
• W4281567298 hasAuthorship W4281567298A5008694922 @default.
• W4281567298 hasAuthorship W4281567298A5010478248 @default.
• W4281567298 hasAuthorship W4281567298A5011668923 @default.
• W4281567298 hasAuthorship W4281567298A5011869206 @default.

• next